The U.S. can’t afford to offshore clinical trials to China

Jacob Becraft is the co-founder and CEO of Strand Therapeutics. In the late 20th century, the United States made a bet that it could offshore manufacturing to countries with cheaper labor, such as China, while leading innovations at home. But although that bet delivered cheaper goods, it also hollo...

Redirecting to full article...